MiR-429 Inhibits the Angiogenesis of Human Brain Microvascular Endothelial Cells through SNAI2-Mediated GSK-3β/β-Catenin Pathway

Figure 1

MiR-429 was significantly upregulated in the serums of patients and downregulated in OGD-induced HBMECs. (a) The relative expression level of miR-429 in the serums of the patients. (b) The relative expression level of miR-429 the HBMECs treated with OGD for 12 h, 24 h, and 48 h. meant .

(a)

(b)